Latka logo
Protembis logo

Protembisrevenue

Aachen, GermanyFounded 2013CEO David Bergmark

Protembis is a medical device company that develops innovative technologies to reduce the risk of new brain injury during cardiology procedures, particularly in connection with transcatheter aortic valve replacement (TAVR).

protembis.comLinkedInUpdated Sep 10, 2026
Annual revenue
$8M
Sep 2025EST
Employees
25
Sep 2025

Protembis revenue

Protembis has not published its revenue. Growjo puts it at about $8M a year (September 2025).

$0
$2M
$4M
$6M
$8M
$0
–
$8M
20132014–242025
ReportedEstimateFounded 2013 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$8MESTGrowjo estimate

Protembis CEO & employees

David Bergmark is CEO of Protembis. Protembis has 25 employees (September 2025, LinkedIn).

0
10
20
25
2025
ReportedOne figure per year; a reported figure wins over an estimate

Protembis FAQ

What is Protembis' revenue?

Growjo estimates Protembis' revenue at about $8M a year (September 2025). The company hasn't published its own figure.

How many employees does Protembis have?

Protembis has 25 employees as of September 2025, according to LinkedIn.

Who is the CEO of Protembis?

David Bergmark is the CEO of Protembis.

Categories

Companies in

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Protembis? Join the podcast